• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西帕金森病患者的疲劳

Fatigue in Brazilian patients with Parkinson's disease.

作者信息

Nassif Daniel Venturino, Pereira João Santos

机构信息

Universidade do Estado do Rio de Janeiro, Hospital Universitário Pedro Ernesto, Departamento de Neurologia, Rio de Janeiro RJ, Brazil.

出版信息

Dement Neuropsychol. 2022 Apr-Jun;16(2):237-242. doi: 10.1590/1980-5764-DN-2021-0083. Epub 2022 May 13.

DOI:10.1590/1980-5764-DN-2021-0083
PMID:35720654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9173788/
Abstract

UNLABELLED

Fatigue is a non-motor symptom of high prevalence in Parkinson's disease (PD); however, it is still unknown and neglected by health professionals.

OBJECTIVE

This study aimed to demonstrate the prevalence of fatigue in patients with PD after excluding confounding factors, as well as its correlation with clinical and demographic data, and to find its negative impact on the quality of life of these patients.

METHODS

A cross-sectional study was carried out with 237 randomly selected patients. According to inclusion and exclusion criteria, we selected 53 patients, who were then submitted to the Fatigue Severity Scale. Clinical and demographic data were also analyzed, comparing them between patients with and without fatigue.

RESULTS

We identified fatigue in 21 (39.62%) patients. Patients with and without fatigue had similar mean scores on the UPDRS-III (p=0.36), equivalent daily dose of levodopa (p=0.94), mean disease duration (p=0.43), and mean age (p<0.99). Fatigued patients had worse quality of life scores (PDQ-39) (p=0.00). We did not observe a correlation between fatigue, duration of illness (r=0.11; p=0.43), age (r=0.00; p=0.99), and UPDRS-III (r=0.20; p=0.16).

CONCLUSIONS

Fatigue is a highly prevalent and independent symptom of PD. There is no correlation between age, mean duration of disease, motor impairment, and its presence. It has a negative impact on quality of life.

摘要

未标注

疲劳是帕金森病(PD)中一种高患病率的非运动症状;然而,它仍然不为人知且被健康专业人员忽视。

目的

本研究旨在证明排除混杂因素后PD患者中疲劳的患病率,以及其与临床和人口统计学数据的相关性,并找出其对这些患者生活质量的负面影响。

方法

对237名随机选择的患者进行了横断面研究。根据纳入和排除标准,我们选择了53名患者,然后让他们接受疲劳严重程度量表评估。还分析了临床和人口统计学数据,对有疲劳和无疲劳的患者进行比较。

结果

我们在21名(39.62%)患者中发现了疲劳。有疲劳和无疲劳的患者在统一帕金森病评定量表第三部分(UPDRS-III)上的平均得分相似(p = 0.36),左旋多巴的日均剂量相当(p = 0.94),平均病程(p = 0.43)和平均年龄(p < 0.99)。疲劳患者的生活质量得分(PDQ-39)更差(p = 0.00)。我们未观察到疲劳与病程(r = 0.11;p = 0.43)、年龄(r = 0.00;p = 0.99)和UPDRS-III(r = 0.20;p = 0.16)之间存在相关性。

结论

疲劳是PD一种高度普遍且独立的症状。年龄、平均病程、运动障碍与其存在之间无相关性。它对生活质量有负面影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb60/9173788/a1fb6bdf8ed5/1980-5764-dn-1980-5764-dn-2021-0083-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb60/9173788/c36389571ba9/1980-5764-dn-1980-5764-dn-2021-0083-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb60/9173788/a1fb6bdf8ed5/1980-5764-dn-1980-5764-dn-2021-0083-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb60/9173788/c36389571ba9/1980-5764-dn-1980-5764-dn-2021-0083-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb60/9173788/a1fb6bdf8ed5/1980-5764-dn-1980-5764-dn-2021-0083-gf2.jpg

相似文献

1
Fatigue in Brazilian patients with Parkinson's disease.巴西帕金森病患者的疲劳
Dement Neuropsychol. 2022 Apr-Jun;16(2):237-242. doi: 10.1590/1980-5764-DN-2021-0083. Epub 2022 May 13.
2
Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment.特发性帕金森病的疲劳和日间过度嗜睡与运动症状、抑郁和多巴胺能治疗有不同的相关性。
Eur J Neurol. 2010 Dec;17(12):1428-36. doi: 10.1111/j.1468-1331.2010.03063.x.
3
Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease.一组中国帕金森病患者便秘的临床特征及相关因素
World J Gastrointest Pharmacol Ther. 2021 Jan 5;12(1):21-31. doi: 10.4292/wjgpt.v12.i1.21.
4
Prevalence of fatigue in Parkinson disease and its clinical correlates.帕金森病疲劳的患病率及其临床相关性。
Neurology. 2014 Jul 15;83(3):215-20. doi: 10.1212/WNL.0000000000000587. Epub 2014 Jun 13.
5
Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.帕金森病非运动症状对健康相关和感知生活质量的影响。
J Neurol Sci. 2013 Sep 15;332(1-2):136-40. doi: 10.1016/j.jns.2013.07.005. Epub 2013 Jul 25.
6
Fatigue in Parkinson's disease: A systematic review and meta-analysis.帕金森病疲劳:系统评价和荟萃分析。
Mov Disord. 2018 Nov;33(11):1712-1723. doi: 10.1002/mds.27461. Epub 2018 Sep 28.
7
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients.帕金森病患者疲劳与其他运动及非运动症状之间的关联
J Neurol. 2014 Feb;261(2):382-91. doi: 10.1007/s00415-013-7207-5. Epub 2013 Dec 28.
8
Clinical characteristics of fatigued Parkinson's patients and the response to dopaminergic treatment.疲劳的帕金森病患者的临床特征及对多巴胺能治疗的反应。
Transl Neurodegener. 2016 May 10;5:9. doi: 10.1186/s40035-016-0056-2. eCollection 2016.
9
The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).帕金森病患者生活质量的关键决定因素:帕金森病生物标志物项目(PDBP)的结果。
J Parkinsons Dis. 2016 May 31;6(3):523-32. doi: 10.3233/JPD-160851.
10
Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire.生活质量与帕金森病:帕金森病问卷的菲律宾语翻译及验证
J Clin Neurosci. 2018 Aug;54:156-160. doi: 10.1016/j.jocn.2018.06.013. Epub 2018 Jun 12.

引用本文的文献

1
Exploring Fatigue in Parkinson's Disease: A Comprehensive Literature Review.探索帕金森病中的疲劳:一项全面的文献综述。
Cureus. 2025 Mar 25;17(3):e81129. doi: 10.7759/cureus.81129. eCollection 2025 Mar.
2
Behavioral disorders in Parkinson disease: current view.帕金森病中的行为障碍:当前观点
J Neural Transm (Vienna). 2025 Feb;132(2):169-201. doi: 10.1007/s00702-024-02846-3. Epub 2024 Oct 25.
3
The impact of fatigue severity and depression level on the quality of life in individuals with Parkinson's disease in Taiwan.

本文引用的文献

1
Progression of fatigue in Parkinson's disease - a 9-year follow-up.帕金森病疲劳的进展 - 9 年随访。
Eur J Neurol. 2021 Jan;28(1):108-116. doi: 10.1111/ene.14520. Epub 2020 Oct 16.
2
Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study.早期首发帕金森病患者疲劳严重程度的预测因素:一项为期 1 年的纵向研究。
Parkinsonism Relat Disord. 2020 Oct;79:3-8. doi: 10.1016/j.parkreldis.2020.08.019. Epub 2020 Aug 15.
3
Identifying and responding to fatigue and apathy in Parkinson's disease: a review of current practice.
台湾帕金森病患者疲劳严重程度和抑郁水平对生活质量的影响。
Front Psychiatry. 2024 Jul 18;15:1309989. doi: 10.3389/fpsyt.2024.1309989. eCollection 2024.
帕金森病中疲劳和冷漠的识别与应对:当前实践综述
Expert Rev Neurother. 2020 May;20(5):477-495. doi: 10.1080/14737175.2020.1752669. Epub 2020 May 3.
4
Neural and dopaminergic correlates of fatigue in Parkinson's disease.帕金森病疲劳的神经和多巴胺能相关性。
J Neural Transm (Vienna). 2020 Mar;127(3):301-309. doi: 10.1007/s00702-019-02130-9. Epub 2020 Jan 2.
5
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.青少年帕金森病:鉴别诊断、遗传学和治疗。
Parkinsonism Relat Disord. 2019 Oct;67:74-89. doi: 10.1016/j.parkreldis.2019.06.025. Epub 2019 Jun 30.
6
Prodromal Parkinson disease: do we miss the signs?帕金森病前驱期:我们是否忽略了这些迹象?
Nat Rev Neurol. 2019 Aug;15(8):437-438. doi: 10.1038/s41582-019-0215-z.
7
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.帕金森病非运动症状治疗的研究进展——基于循证医学的评价
Mov Disord. 2019 Feb;34(2):180-198. doi: 10.1002/mds.27602. Epub 2019 Jan 17.
8
The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management.帕金森病疲劳的病理生理学及其实用管理
Mov Disord Clin Pract. 2016 Mar 11;3(4):323-330. doi: 10.1002/mdc3.12343. eCollection 2016 Jul-Aug.
9
Fatigue in Parkinson's disease: A systematic review and meta-analysis.帕金森病疲劳:系统评价和荟萃分析。
Mov Disord. 2018 Nov;33(11):1712-1723. doi: 10.1002/mds.27461. Epub 2018 Sep 28.
10
Fatigue in Parkinson's disease: concepts and clinical approach.帕金森病中的疲劳:概念与临床处理方法
Psychogeriatrics. 2018 Mar;18(2):143-150. doi: 10.1111/psyg.12302. Epub 2018 Feb 6.